Walter E. DeWolf

3.4k citations

50 papers · 1.9k indexed · h-index 26

Microbiology top 2%
- Antimicrobial Peptides and Activities 6
Molecular Medicine top 5%
Organic Chemistry top 5%
- Antimicrobial agents and applications 6
Molecular Biology top 10%
- Cell death mechanisms and regulation 4
- Metabolism, Diabetes, and Cancer 4
- Protein Structure and Dynamics 3
Biochemistry top 5%
- Biochemical Acid Research Studies 6
Surgery
- Pancreatic function and diabetes 5
Pediatrics, Perinatology and Child Health
- Neonatal Health and Biochemistry 3

Co-authors: Lawrence I. Kruse Paul M. Keller David Payne Paula J. Goodhart Vern L. Schramm Terrance Moore Stephen Rittenhouse Dennis Lee
Cited by: Microbiology Molecular Medicine Organic Chemistry
Journals: Journal of Medicinal Chemistry (11 papers)Biochemistry (7 papers)Journal of Biological Chemistry (5 papers)
Partner nations: United States United Kingdom Russia

In The Last Decade

Walter E. DeWolf

50 papers receiving 1.8k citations

Peers

Countries citing papers authored by Walter E. DeWolf

Since Specialization

Citations

This map shows the geographic impact of Walter E. DeWolf's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Walter E. DeWolf with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Walter E. DeWolf more than expected).

Fields of papers citing papers by Walter E. DeWolf

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Walter E. DeWolf. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Walter E. DeWolf. The network helps show where Walter E. DeWolf may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Walter E. DeWolf, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Walter E. DeWolf Line = papers co-authored together Walter E. DeWolf links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Discovery and preclinical development of AR453588 as an anti-diabetic glucokinase activator Bioorganic & Medicinal Chemistry ·Ronald J. Hinklin,Brian R. Baer,Steven A. Boyd,M. I. Asensio-Sevillana,Kevin R. Condroski,Walter E. DeWolf,John P. Fischer,Vishal Patole,Gary P. Hingorani,Patrice A. Lee,merlinkun,A. Froehlich,Ajay Singh,Francis X. Sullivan,B. V. Bokut',W.C. Voegtli,Eli M. Wallace,呂建新,Thomas D. Aicher	2019	10
2	Characterization of a Novel Glucokinase Activator in Rat and Mouse Models PLoS ONE ·Min Lü,Pingping Li,Gautam Bandyopadhyay,William Lagakos,Walter E. DeWolf,A. Eggemeier,Mark J. Chicarelli,呂建新,Deborah Anderson,Brian R. Baer,Maralee McVean,Marion Conn,Murielle M. Véniant,Peter Coward	2014	16
3	Prodrug thiamine analogs as inhibitors of the enzyme transketolase Bioorganic & Medicinal Chemistry Letters ·Yvan Le Huérou,Indrani W. Gunawardana,Allen A. Thomas,Steven A. Boyd,Sapitri Juliana,Walter E. DeWolf,Joshua Immanuvel Lavy,May Han,M. V. Kiyak,Régis Jauffret,Christine Lemieux,Patrice Lee,Jemwel Aron,G Pöch,Todd T. Romoff,Francis Sullivan,Solly Weiler,S. Kirk Wright,Jie Lin	2007	20
4	Role of caspases in human renal proximal tubular epithelial cell apoptosis European Journal of Pharmacology ·M. G. Broens,Paul M. Keller,Mark Nuttall,Kristine Kikly,Walter E. DeWolf,Dennis Lee,Shujath M. Ali,Daniel P. Nadeau,Eugene T. Grygielko,Nicholas J. Laping,David P. Brooks	2001	13
5	1,4-Disubstituted imidazoles are potential antibacterial agents functioning as inhibitors of enoyl acyl carrier protein reductase (FabI) Bioorganic & Medicinal Chemistry Letters ·Dirk A. Heerding,George Chan,Walter E. DeWolf,Andrew Fosberry,Cheryl A. Janson,Deborah D. Jaworski,Edward C. McManus,William H. Miller,Terrance Moore,David Payne,Xiayang Qiu,Stephen Rittenhouse,D. Grannes,Ward W. Smith,Dennis T. Takata,Ana Solà Fernández,Catherine Yuan,William F. Huffman	2001	110
6	Structure-based combinatorial library design: Discovery of non-peptidic inhibitors of caspases 3 and 8 Journal of Computer-Aided Molecular Design ·Martha S. Head,Margret Ryan,Dennis Lee,P. Shipkovs,Cheryl A. Janson,N.O. Concha,Paul M. Keller,Walter E. DeWolf	2001	3
7	Inhibitors of bacterial enoyl acyl carrier protein reductase (FabI): 2,9-disubstituted 1,2,3,4-tetrahydropyrido[3,4-b]indoles as potential antibacterial agents Bioorganic & Medicinal Chemistry Letters ·Mark A. Seefeld,William H. Miller,Kenneth A. Newlander,泰治桑田,David Payne,Stephen Rittenhouse,Terrance Moore,Walter E. DeWolf,Paul M. Keller,Xiayang Qiu,Cheryl A. Janson,Kalindi Vaidya,Andrew Fosberry,Martin G. Smyth,Deborah D. Jaworski,D. Grannes,William F. Huffman	2001	52
8	Simplified Velocity Equations for Characterizing the Partial Inhibition or Nonessential Activation of Bireactant Enzymes Journal of enzyme inhibition ·Walter E. DeWolf,Irwin H. Segel	2000	2
9	Inhibition of caspase‐3‐like activity prevents apoptosis while retaining functionality of human chondrocytes in vitro Journal of Orthopaedic Research® ·Mark Nuttall,Daniel P. Nadeau,Paul W. Fisher,Feilan Wang,Paul M. Keller,Walter E. DeWolf,Mary B. Goldring,Alison M. Badger,Dennis Lee,Mark A. Levy,Maxine Gowen,Michael W. Lark	2000	79
10	TL1, a Novel Tumor Necrosis Factor-like Cytokine, Induces Apoptosis in Endothelial Cells Journal of Biological Chemistry ·Tianli Yue,Jian Ni,Anne M. Romanic,Juan-Li Gu,Paul M. Keller,Chuanlin Wang,Sanjay Kumar,Guoliang Yu,Timothy K. Hart,Xinkang Wang,Zhengui Xia,Walter E. DeWolf,Giora Feuerstein	1999	95
11	Role of Conserved Histidines in Catalytic Activity and Inhibitor Binding of Human Recombinant Phosphodiesterase 4A Molecular Pharmacology ·Susanne Jacobitz,Margret Ryan,Megan M. McLaughlin,George P. Livi,Walter E. DeWolf,Theodore J. Torphy	1997	20
12	Endothelin-Converting Enzyme: Substrate Specificity and Inhibition by Novel Analogs of Phosphoramidon Biochemical and Biophysical Research Communications ·Paul M. Keller,Chao‐Pin Lee,Ashley Fenwick,K Tirupathi,John D. Elliott,Walter E. DeWolf	1996	16
13	Use of a continous assay of oxygen consumption to evaluate the pharmacology of 5-lipoxygenase inhibitors Prostaglandins Leukotrienes and Essential Fatty Acids ·John Breton,Paul M. Keller,Marie Chabot‐Fletcher,Leonard M. Hillegass,Walter E. DeWolf,D.E. Griswold	1993	9
14	Biochemical Characteristics and Cellular Regulation of Phosphodiesterase IV Birkhäuser Basel eBooks ·Theodore J. Torphy,Walter E. DeWolf,David W. Green,G P Livi	1993	22
15	Expression of human preproendothelin-1 cDNA in cos cells results in the production of mature vasoactive endothelin-1 Biochemical and Biophysical Research Communications ·Anthony G. DiLella,Yalong,Nabil A. Elshourbagy,Pradip K. Bhatnagar,Ponnal Nambi,Walter E. DeWolf,Madelyn M. Caltabiano	1991	3
16	Some benzyl-substituted imidazoles, triazoles, tetrazoles, pyridinethiones, and structural relatives as multisubstrate inhibitors of dopamine .beta.-hydroxylase. 4. Structure-activity relationships at the copper binding site Journal of Medicinal Chemistry ·Lawrence I. Kruse,Carl Kaiser,Walter E. DeWolf,Joseph A. Finkelstein,James S. Frazee,Asep Sapaatullah,Stephen T. Ross,Kathryn E. Flaim,John L. Sawyer	1990	42
17	Inactivation of dopamine .beta.-hydroxylase by .beta.-ethynyltyramine: kinetic characterization and covalent modification of an active site peptide Biochemistry ·Walter E. DeWolf,Pamela A. Chambers,Christopher Southan,David Saunders,Lawrence I. Kruse	1989	20
18	Effects of the novel dopamine beta-hydroxylase inhibitor SK&F 102698 on catecholamines and blood pressure in spontaneously hypertensive rats. Journal of Pharmacology and Experimental Therapeutics ·Barry A. Berkowitz,Anthony J. Arleth,C P Sung,Lawrence I. Kruse,Walter E. DeWolf,Kai Jian Yang	1988	1
19	Inactivation of dopamine .beta.-hydroxylase by p-cresol: isolation and characterization of covalently modified active site peptides Biochemistry ·Walter E. DeWolf,Steven A. Carr,Angela Varrichio,Paula J. Goodhart,Y. Matsuda,Gerald D. Roberts,Christopher Southan,Roland E. Dolle,Lawrence I. Kruse	1988	55
20	.beta.-Substituted phenethylamines as high-affinity mechanism-based inhibitors of dopamine .beta.-hydroxylase Journal of Medicinal Chemistry ·Lawrence I. Kruse,Carl Kaiser,Walter E. DeWolf,Pamela A. Chambers,Paula J. Goodhart,Tae Wan Eom,Eliot H. Ohlstein	1988	28

About Walter E. DeWolf

Walter E. DeWolf is a scholar working on Biochemistry, Microbiology and Physiology, having authored 50 papers that have together received 1.9k indexed citations. Recurring topics across this work include Antimicrobial agents and applications (6 papers), Antimicrobial Peptides and Activities (6 papers), Biochemical Acid Research Studies (6 papers), Pancreatic function and diabetes (5 papers), Cell death mechanisms and regulation (4 papers), Metabolism, Diabetes, and Cancer (4 papers), Protein Structure and Dynamics (3 papers) and Neonatal Health and Biochemistry (3 papers). The work is most often cited by research in Microbiology (190 citations), Molecular Medicine (139 citations) and Organic Chemistry (620 citations). Walter E. DeWolf has collaborated with scholars based in United States, United Kingdom and Russia. Frequent co-authors include Lawrence I. Kruse, Paul M. Keller, David Payne, Paula J. Goodhart, Vern L. Schramm, Terrance Moore, Stephen Rittenhouse, Dennis Lee, William H. Miller and Xiayang Qiu. Their work appears in journals such as Journal of Medicinal Chemistry, Biochemistry, Journal of Biological Chemistry, Bioorganic & Medicinal Chemistry Letters and Journal of Pharmacology and Experimental Therapeutics.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact